Evidence map›Paper›PMID 38865329›Full record

ArticlePloS one2024

Enhancing clinical decision-making: Sysmex UF-5000 as a screening tool for bacterial urinary tract infection in children.

Ping Liu, Chuanwei Ban, Juan Wang, Qian Zeng, Mengmeng Chen, Ling Wang, Xin Lv

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ping LiuClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Chuanwei BanClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Juan WangClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Qian ZengClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Mengmeng ChenClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Ling WangClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.
Xin LvClinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, China.ORCID 0000-0003-4630-9305

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA rapid screening test for urinary tract infections (UTIs) in children is needed to avoid unnecessary cultures and provide prompt reports to make appropriate clinical decisions. We have evaluated for the first time the performance of the Sysmex UF-5000 flow cytometer as a screening tool for UTIs in children.

methodsThis study included 4445 pediatric patients, with urinary sediment and urine culture data collected from January 2020 to September 2023. The Sysmex UF-5000 analyzer was utilized to measure urine white blood cell (WBC) and bacteria (BACT), with the findings being compared to the culture results.

resultsAt ≥ 104 colony-forming unit (CFU)/mL, 513 samples were culture-positive (400 samples presented 104-105 CFU/mL, and 113 demonstrated ≥ 105 CFU/mL bacterial growth). Optimal indicators for positive cultures were BACT counts of 92.2/μL (AUC: 0.944) and WBC counts of 40.8/μL (AUC:0.863). False negative rate were 0.9% when using a 7.8 bacteria/μL cut-off and avoiding unnecessary cultures in 28.1%. The UF-5000 has a higher consistency rate for Gram-negative (GN) bacteria (90.3%) than Gram-positive (GP) bacteria (86.8%). For samples with 105 CFU/mL, UF-5000's Bacteria -Information flags showed superior concordance for samples with 104-105 CFU/mL bacteria.

conclusionsScreening pediatric urine cultures with the UF-5000 showed potential application value in identifying negative cultures and significant bacterial growth, although performance may vary depending on the study population. Furthermore, detecting Gram typing aids in guiding early clinical empirical medication, particularly for UTIs caused by GN bacteria.

Indexed as

Clinical Decision-MakingUrinary Tract InfectionsAdolescentChildChild, PreschoolFemaleFlow CytometryHumansInfantInfant, NewbornLeukocyte CountMaleMass ScreeningUrinalysis

Identifiers

PMID38865329
PMCPMC11168643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.